mitomycin has been researched along with linezolid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bock, M; Bruun, NE; Bundgaard, H; Christensen, JJ; Christiansen, U; Elming, H; Fosbøl, EL; Fuursted, K; Gill, S; Helweg-Larsen, J; Høfsten, DE; Høiby, N; Ihlemann, N; Iversen, K; Køber, L; Moser, C; Povlsen, JA; Pries-Heje, MM; Rosenvinge, FS; Schwartz, F; Torp-Pedersen, C; Tønder, N; Van Hasselt, JGC; Wang, H | 1 |
1 review(s) available for mitomycin and linezolid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for mitomycin and linezolid
| Article | Year |
|---|---|
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Humans; Linezolid; Mitomycin; Rifampin | 2023 |